MEDI-1814

• Target:

  Beta Amyloid

• Related Pathways:

  Neuroscience

• Bioactivity:

  MEDI-1814 is a fully human IgG1 antibody targeting the C-terminus of A?42. It binds to and eliminates circulating A? peptides, thereby preventing their aggregation into toxic oligomers. MEDI-1814 is applicable in Alzheimer's disease research. For an isotype control, refer to HumanIgG1kappa, Isotype Control.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C